Format

Send to

Choose Destination
Ann Surg. 2002 Mar;235(3):440-3.

Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer.

Author information

1
Department of Molecular Biology, University of Southern California Keck School of Medicine, Los Angeles, California, USA. drbrabender@cs.com

Erratum in

  • Ann Surg 2002 Jun;235(6):896-7.

Abstract

OBJECTIVE:

To investigate cyclooxygenase-2 (COX-2) mRNA expression in curatively resected non-small cell lung cancer (NSCLC) and to determine its association with prognosis.

SUMMARY BACKGROUND DATA:

Lung cancer is one of the most common malignancies in the world. Despite improvements in the diagnosis and treatment of NSCLC, the 5-year survival rate remains less than 15%. Identification of prognostic predictors based on molecular alterations could lead to additional diagnostic tools and eventually to more effective therapeutic options. Overexpression of COX-2 has been reported in several human malignancies, including lung cancer, but the prognostic importance of this overexpression has not been elucidated.

METHODS:

COX-2 mRNA expression was analyzed using a quantitative real-time polymerase chain reaction (Taqman) method in surgically resected tumor specimens from 89 patients with curatively resected NSCLC.

RESULTS:

COX-2 mRNA was detectable in all 89 (100%) tumor tissues. High COX-2 expression in tumors was significantly associated with inferior survival. Multivariate analysis showed that high COX-2 expression is an independent predictor of worse survival in patients with NSCLC.

CONCLUSIONS:

High COX-2 mRNA expression is an important biomarker for biologically aggressive disease in NSCLC and might be helpful in identifying patients who would benefit from additional therapies for controlling their disease.

PMID:
11882767
PMCID:
PMC1422451
DOI:
10.1097/00000658-200203000-00017
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center